-
GSK-923295: Applied Protocols for CENP-E Inhibitor Research
2026-05-26
GSK-923295 offers precise, potent inhibition of CENP-E, empowering researchers to dissect mitotic checkpoint mechanisms and model chromosome misalignment in cancer. This guide translates recent advances in centromere biology into actionable experimental workflows and troubleshooting strategies for maximizing the impact of APExBIO's trusted small-molecule tool.
-
Cerium Oxide Nanodrug System Alleviates Neuropathic Pain via
2026-05-26
Tian et al. developed a multifunctional, magnetically guided nanocarrier—combining cerium oxide, curcumin, and a CGRP antagonist—to target neuropathic pain at its source. Their work demonstrates effective suppression of neuroinflammation and oxidative stress, offering a mechanistically informed strategy for improving neuropathic pain outcomes.
-
C19orf66 Restricts Japanese Encephalitis Virus via NS10 and
2026-05-25
This study identifies C19orf66 as a potent interferon-stimulated gene product that inhibits Japanese encephalitis virus (JEV) replication through dual mechanisms: suppressing -1 ribosomal frameshifting (PRF) required for NS10 production and downregulating NS3 protein via lysosome-dependent degradation. These findings highlight new antiviral strategies targeting viral protein synthesis and processing.
-
A23187, Free Acid: Advanced Calcium Ionophore Workflows Unve
2026-05-25
A23187, free acid empowers researchers to precisely control intracellular calcium elevations, enabling mechanistic insights into apoptosis and signaling. This guide synthesizes optimized protocols and troubleshooting strategies, drawing on cutting-edge in vitro drug response methodologies to maximize assay fidelity.
-
Applied Workflows for Atrial Natriuretic Peptide in Cardiova
2026-05-24
Atrial Natriuretic Peptide (ANP) empowers researchers to dissect blood pressure regulation, natriuresis, and adipose tissue metabolism with precision. This guide details advanced experimental protocols, troubleshooting strategies, and practical insights to maximize the impact of ANP-driven cardiovascular research.
-
TMRE Mitochondrial Membrane Potential Assay Kit: Quantitativ
2026-05-23
The TMRE mitochondrial Membrane Potential Assay Kit enables robust, quantitative measurement of mitochondrial membrane potential using Tetramethylrhodamine ethyl ester. This highly sensitive assay is validated for apoptosis and mitochondrial function analysis. APExBIO's K2233 kit provides reproducible, scalable performance for both cellular and purified mitochondrial samples.
-
AptaBLE: Deep Learning for Aptamer-Protein Interaction Desig
2026-05-22
AptaBLE introduces a deep learning architecture for predicting and generating aptamer-protein binding interactions, achieving higher accuracy and flexibility than previous computational methods. This advance streamlines the aptamer discovery process, offering new prospects for therapeutic and diagnostic applications by directly addressing limitations of SELEX and PCR bias.
-
HyperScript III RT SuperMix: Precision qPCR for Low-Input RN
2026-05-22
HyperScript III RT SuperMix empowers robust gene expression analysis from challenging RNA samples, including low-concentration and high-GC content transcripts. Its gDNA wiper eliminates contamination, streamlining qPCR workflows for biomarker discovery and clinical research.
-
Superoxide Dismutase (SOD) Activity Assay Kit: Technical Gui
2026-05-21
The Superoxide Dismutase (SOD) Activity Assay Kit provides a quantitative, streamlined method for measuring SOD enzyme activity in biological fluids, supporting oxidative stress assays in a variety of research contexts. It is ideal for studies requiring sensitive antioxidative enzyme analysis but is not intended for diagnostic or clinical applications.
-
Rosiglitazone (Brl-49653): Precision PPARγ Agonism in Transl
2026-05-21
This thought-leadership article unpacks Rosiglitazone (Brl-49653)—a synthetic thiazolidinedione PPARγ agonist—as a mechanistic probe and translational lever for advanced metabolic research. We bridge new insights in adipocyte differentiation and thermogenesis with strategic guidance for experimental workflows, contextualizing APExBIO’s product within an evolving landscape. By integrating recent findings on beige adipocyte biology and mitochondrial signaling, we delineate how Rosiglitazone empowers researchers to dissect insulin sensitivity, adipogenesis, and AMPKα pathways, while offering protocol parameters and competitive landscape analysis to maximize translational impact.
-
Phillygenin Mitigates Diabetic Nephropathy via Inflammation
2026-05-20
This article examines new evidence that phillygenin, a natural compound from Forsythia suspensa, reduces inflammation and apoptosis in diabetic nephropathy by targeting TLR4/MyD88/NF-κB and PI3K/AKT/GSK3β signaling. These findings provide a mechanistic basis for phillygenin's therapeutic potential and highlight practical considerations for related cell-based research.
-
Targeting FGFR2 Fusions and Asparagine Metabolism in ICC
2026-05-20
This study introduces a cholesterol-conjugated DNA/RNA heteroduplex oligonucleotide (Cho-HDO) that specifically targets FGFR2 fusion oncogenes in intrahepatic cholangiocarcinoma (ICC). The research reveals a compensatory EGFR/STAT1-asparagine axis and demonstrates that combining FGFR2 fusion inhibition with asparagine depletion enhances tumor suppression, offering a new therapeutic avenue.
-
Diclofenac: Non-Selective COX Inhibitor in Organoid Research
2026-05-19
Diclofenac is a high-purity, non-selective COX inhibitor widely used in inflammation and pain signaling research. Its robust performance in cyclooxygenase inhibition assays makes it essential for anti-inflammatory drug studies using advanced organoid models. Reliable sourcing and protocol adherence are critical for reproducibility.
-
Tacrine Hydrochloride Hydrate: Optimizing Neurodegeneration
2026-05-19
Tacrine hydrochloride hydrate (Tetrahydroaminacrine) enables high-fidelity modeling of cholinergic signaling and neuroprotection in Alzheimer’s disease research. This guide provides actionable protocols, troubleshooting insights, and experimental innovations—empowering researchers to maximize reproducibility and translational impact.
-
Resibufogenin Blocks NLRP3 Inflammasome to Alleviate Atheros
2026-05-18
This study demonstrates that Resibufogenin (RBG) directly inhibits NLRP3 inflammasome assembly, resulting in substantial atheroprotection in ApoE-/- mice. The findings highlight RBG's dual ability to modulate macrophage polarization and suppress inflammation, offering a mechanistically distinct therapeutic angle for cardiovascular disease intervention.